| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.003 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |